Cite
Increased NLRP3 inflammasome activation and pyroptosis in multiple sclerosis patients with fingolimod treatment failure
MLA
Sunny Malhotra, et al. Increased NLRP3 Inflammasome Activation and Pyroptosis in Multiple Sclerosis Patients with Fingolimod Treatment Failure. July 2022. EBSCOhost, https://doi.org/10.21203/rs.3.rs-1831031/v1.
APA
Sunny Malhotra, Laura Hurtado-Navarro, Agustin Pappolla, Luisa M Villar, Jordi Río, Xavier Montalban, Pablo Pelegrin, & Manuel Comabella. (2022). Increased NLRP3 inflammasome activation and pyroptosis in multiple sclerosis patients with fingolimod treatment failure. https://doi.org/10.21203/rs.3.rs-1831031/v1
Chicago
Sunny Malhotra, Laura Hurtado-Navarro, Agustin Pappolla, Luisa M Villar, Jordi Río, Xavier Montalban, Pablo Pelegrin, and Manuel Comabella. 2022. “Increased NLRP3 Inflammasome Activation and Pyroptosis in Multiple Sclerosis Patients with Fingolimod Treatment Failure,” July. doi:10.21203/rs.3.rs-1831031/v1.